Ravi Prakash Sahu (Ravi P Sahu)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Medical sciences (Basel, Switzerland)

BioFactors (Oxford, England)

Platelets

Cancer research

Wright State University

Sanjay Gandhi Post Graduate Institute of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wright State University Jul 01 2015

United States

Assistant Professor

Indiana University School of Medicine Oct 01 2012

United States

Assistant Professor

Indiana University School of Medicine Jun 01 2009

United States

Postdoc

Texas Tech University Health Sciences Center Jun 01 2007

United States

Postdoc

University of Pittsburgh Medical Center Jan 04 2007

United States

Postdoc

Education History

Sanjay Gandhi Post Graduate Institute of Medical Sciences Jun 01 2001

India

PHD :: Molecular Endocrinology

Dr. R.M.L. Avadh University Jun 01 1999

India

MSC

University of Allahabad Jul 01 1995

India

BSC

Publications

Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, Ravi Prakash Sahu
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer. Medical sciences (Basel, Switzerland) 12 (2) (2024)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) 48 (6) (2022)
Zaid Sirhan, Anita Thyagarajan, Ravi Prakash Sahu
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer. Military Medical Research 9 (1) (2022)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) 48 (6) (2022)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) 48 (6) (2022)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) 48 (6) (2022)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) 48 (6) (2022)
Anita Thyagarajan, Krishna Awasthi, Christine M Rapp, R Michael Johnson, Yanfang Chen, Kelly L R Miller, Jeffrey B Travers, Ravi Prakash Sahu
SI: PAF: Topical application of gemcitabine generates microvesicle particles in human and murine skin. BioFactors (Oxford, England) (2022)
Kandahalli Venkataranganayaka Abhilasha, Mosale Seetharam Sumanth, Anita Thyagarajan, Ravi Prakash Sahu, Kemparaju Kempaiah, Gopal Kedihithlu Marathe
Reversible cross-tolerance to platelet-activating factor signaling by bacterial toxins. Platelets 32 (7) (2020)
Ravi Prakash Sahu
Deciphering Mechanisms of UVR-Induced Tumoral Immune Checkpoint Regulation against Melanoma. Cancer research 79 (11) (2019)

Ravi Prakash Sahu.css-eqlu8i{font-size:small;padding-left:4px;} (Ravi P Sahu)

Publication Activity (10 Years)

Top Topics

Top Venues

Ravi Prakash Sahu (Ravi P Sahu)